Showing 1 - 12 results of 12 for search 'Laurence Brunet', query time: 0.05s
Refine Results
-
1
Imaginaire linguistique et acquisition de la langue by Laurence Brunet-Hunault
Published 1996-03-01
Article -
2
Quelle place pour le droit aux origines de l’enfant adopté en France et au Québec by Michelle Giroux, Laurence Brunet
Published 2021-05-01
Article -
3
-
4
Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes by Ricky K. Hsu, Jennifer S. Fusco, Cassidy E. Henegar, Vani Vannappagari, Andrew Clark, Laurence Brunet, Philip C. Lackey, Gerald Pierone, Gregory P. Fusco
Published 2023-02-01
Article -
5
HIV retention in care: results and lessons learned from the Positive Pathways Implementation Trial by Michael B. Wohlfeiler, Rachel Palmieri Weber, Laurence Brunet, Jennifer S. Fusco, Christine Uranaka, Quateka Cochran, Monica Palma, Tammeka Evans, Carl Millner, Gregory P. Fusco
Published 2022-11-01
Article -
6
HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA® observational database: a cohort study by Karam Mounzer, Ricky Hsu, Jennifer S. Fusco, Laurence Brunet, Cassidy E. Henegar, Vani Vannappagari, Chris M. Stainsby, Mark S. Shaefer, Leigh Ragone, Gregory P. Fusco
Published 2019-01-01
Article -
7
Virologically suppressed switch to Dolutegravir/Lamivudine 2-Drug regimen versus switch to commonly prescribed 3-Drug regimens in the United States by Gerald Pierone, Jennifer S. Fusco, Laurence Brunet, Vani Vannappagari, Supriya Sarkar, Cassidy E. Henegar, Jean van Wyk, Michael B. Wohlfeiler, Anthony Mills, Gregory P. Fusco
Published 2024-10-01
Article -
8
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study by Anthony M. Mills, Laurence Brunet, Jennifer S. Fusco, Michael B. Wohlfeiler, Cindy P. Garris, Alan K. Oglesby, Joseph M. Mrus, Philip C. Lackey, Gregory P. Fusco
Published 2019-11-01
Article -
9
Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR by Christina M. Wyatt, Juhi Chaudhari, Shiyuan Miao, Zipporah Krishnasami, James Hellinger, Andrew S. Levey, Michael Ross, Lene Ryom, Amanda Mocroft, Laurence Brunet, Jennifer Fusco, Lesley A. Inker
Published 2020-05-01
Article -
10
Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial by Michael B. Wohlfeiler JD, MD, AAHIVS, Laurence Brunet PhD, Quateka Cochran MSNEd, RN, ACRN, Jennifer S. Fusco BS, Ricky K. Hsu MD, Gregory P. Fusco MD, MPH
Published 2024-04-01
Article -
11
Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort by Michael G. Sension, Laurence Brunet, Ricky K. Hsu, Jennifer S. Fusco, Quateka Cochran, Christine Uranaka, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Lewis McCurdy, Michael B. Wohlfeiler, Gregory P. Fusco
Published 2023-11-01
Article -
12
Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. by Keertan Dheda, Virginia Davids, Laura Lenders, Teri Roberts, Richard Meldau, Daphne Ling, Laurence Brunet, Richard van Zyl Smit, Jonathan Peter, Clare Green, Motasim Badri, Leonardo Sechi, Surendra Sharma, Michael Hoelscher, Rodney Dawson, Andrew Whitelaw, Jonathan Blackburn, Madhukar Pai, Alimuddin Zumla
Published 2010-03-01
Article